Therapeutics & drug development that raised money in Maryland
In the last 30 days, 3 therapeutics & drug development businesses in Maryland reported raising $125K on SEC Form D. The largest was Uvantis Therapeutics, Inc. ($100K), and Monrovia led with 2 raises.
- New raises
- 6
- Capital reported
- $40.3M
- Median raise
- $125K
Aug 3, 2026 to Oct 16, 2026
sold to investors so far
among raises with sales
| Company | Location | Sector | Raised | Target | Filed |
|---|---|---|---|---|---|
| Monocacy Therapeutics Inc. | Monrovia, MD | Health Care | $25K | $25K | |
| Uvantis Therapeutics, Inc. | Columbia, MD | Health Care | $100K | $5M | |
| Monocacy Therapeutics Inc. | Monrovia, MD | Health Care | $49 | $49 | |
| Savannah Therapeutics, Inc | Riverdale, MD | Health Care | $3.9M | $6M | |
| Monocacy Therapeutics Inc. | Monrovia, MD | Health Care | $150K | $150K | |
| Theradaptive, Inc. | Frederick, MD | Health Care | $36.2M | $77.9M |
Therapeutics & drug development nationwide · All raises in Maryland · Filter these →